Pancreatic Cancer Research

ResearcherOklahoma State UniversityNo recent work listed

David Wallace

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8596-7338. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 2 papers · 2020: none · 2021: none · 2022: 2 papers

Papers 5

  1. Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00204-021-03196-9↗
  2. Nickel's Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs. Co-author DOI 10.3390/toxics10030148↗
  3. Environmental cadmium exposure and pancreatic cancer: Evidence from case control, animal and in vitro studies. First author DOI 10.1016/j.envint.2019.04.048↗
  4. Potential interaction of cadmium chloride with pancreatic mitochondria: Implications for pancreatic cancer. Co-author DOI 10.3892/ijmm.2019.4204↗
  5. Cadmium Exposure as a Putative Risk Factor for the Development of Pancreatic Cancer: Three Different Lines of Evidence. First author DOI 10.1155/2017/1981837↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Aleksandra Buha Djordjević · 5 shared papers, 2017–2022 · strength 0.61
  2. Maria Mortoglou · 2 shared papers, 2022 · strength 0.32
  3. Pinar Uysal Onganer · 2 shared papers, 2022 · strength 0.32
  4. Dejan V. Radenkovic · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.